Cargando…
Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
BACKGROUND: Non-small cell lung cancer (NSCLC) was usually associated with poor prognosis and invalid therapeutical response to immunotherapy due to biological heterogeneity. It is urgent to screen reliable biomarkers, especially immunotherapy-associated biomarkers, that can predict outcomes of thes...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628446/ https://www.ncbi.nlm.nih.gov/pubmed/34844602 http://dx.doi.org/10.1186/s12890-021-01765-3 |